Search Results for "Monty Pal" | Oncology Voice Network

Tom Caravela

MSL Retention – What Matters Most

Mar 15^th • 2 mins read

Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11^th • 4 mins read

K. Ribi, N. Kalbermatten, M. Eicher, F. Strasser

Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent

Jun 1^st • 25 mins read

Ariadna Tibau, Consolación Molto, Alberto Ocana, Arnoud J Templeton, Luis P Del Carpio, Joseph C Del Paggio, Agustí Barnadas, Christopher M Booth, Eitan Amir

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

Dec 13^th • 7 mins read

Navigation

Results for 'Monty Pal'

MSL Retention – What Matters Most

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

Related Topics